Seasonal malaria chemoprophylaxis (SMC) is the intermittent administration of therapeutic doses of antimalarial drugs to children at high risk of severe malaria living in areas with seasonal transmission, whether or not they are infected with malaria. In 2012, the World Health Organization recommended SMC as a safe and cost-effective strategy to complement other control efforts such as vector control measures, timely diagnosis and treatment of confirmed cases. To support its implementation, WHO developed the first field guide in 2013.
This second edition builds on over 10 years of SMC deployment and reflects changes made to the WHO malaria control guidance on June 3, 2022. The purpose of this post is to share these best practices to improve SMC implementation, coverage, monitoring and evaluation. Includes examples of materials and tools, as well as links to resources, to support leaders and health workers in their efforts to develop successful SMC campaigns and prevent malaria among vulnerable children.
Post time: Jun-05-2023